Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):627–631. doi: 10.1111/j.1476-5381.1992.tb09030.x

Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C.

T R Walker 1, S P Watson 1
PMCID: PMC1908475  PMID: 1628149

Abstract

1. The effect of okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A (PP1 and PP2A), on human platelets has been investigated. 2. Okadaic acid exerts a general increase in phosphorylation of platelet proteins but did not induce aggregation or secretion of 5-hydroxytryptamine (5-HT). Okadaic acid, however, did inhibit thrombin-induced functional responses. 3. Maximally effective concentrations of prostacyclin, to elevate adenosine 3'-5'-cyclic monophosphate (cyclic AMP), or phorbol dibutyrate, to activate protein kinase C, inhibited the formation of inositol phosphates by thrombin by approximately 60%. When used in combination, prostacyclin and phorbol dibutyrate reduced the levels of inositol phosphates induced by thrombin to 11%. 4. Okadaic acid (1 microM) decreased thrombin-induced formation of inositol phosphates by approximately 55% and increased the inhibitory action of prostacyclin or phorbol dibutyrate. Okadaic acid had no further effect when prostacyclin and phorbol dibutyrate were used in combination. 5. These results suggest that protein kinases A and C act to inhibit phospholipase C by distinct mechanisms and that their action is reversed by PP1 and/or PP2A.

Full text

PDF
627

Images in this article

628Figure 1
on p.628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldassare J. J., Henderson P. A., Fisher G. J. Isolation and characterization of one soluble and two membrane-associated forms of phosphoinositide-specific phospholipase C from human platelets. Biochemistry. 1989 Jul 11;28(14):6010–6016. doi: 10.1021/bi00440a043. [DOI] [PubMed] [Google Scholar]
  2. Banno Y., Nakashima S., Nozawa Y. Partial purification of phosphoinositide phospholipase C from human platelet cytosol; characterization of its three forms. Biochem Biophys Res Commun. 1986 Apr 29;136(2):713–721. doi: 10.1016/0006-291x(86)90498-5. [DOI] [PubMed] [Google Scholar]
  3. Banno Y., Yada Y., Nozawa Y. Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets. J Biol Chem. 1988 Aug 15;263(23):11459–11465. [PubMed] [Google Scholar]
  4. Banno Y., Yu A., Nakashima T., Homma Y., Takenawa T., Nozawa Y. Purification and characterization of a cytosolic phosphoinositide-phospholipase C (gamma 2-type) from human platelets. Biochem Biophys Res Commun. 1990 Mar 16;167(2):396–401. doi: 10.1016/0006-291x(90)92035-x. [DOI] [PubMed] [Google Scholar]
  5. Cohen P., Alemany S., Hemmings B. A., Resink T. J., Strålfors P., Tung H. Y. Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol. 1988;159:390–408. doi: 10.1016/0076-6879(88)59039-0. [DOI] [PubMed] [Google Scholar]
  6. Cohen P., Holmes C. F., Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci. 1990 Mar;15(3):98–102. doi: 10.1016/0968-0004(90)90192-e. [DOI] [PubMed] [Google Scholar]
  7. Ferrell J. E., Jr, Martin G. S. Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets. J Biol Chem. 1989 Dec 5;264(34):20723–20729. [PubMed] [Google Scholar]
  8. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988 Jul 1;241(4861):42–52. doi: 10.1126/science.3291115. [DOI] [PubMed] [Google Scholar]
  9. Haystead T. A., Sim A. T., Carling D., Honnor R. C., Tsukitani Y., Cohen P., Hardie D. G. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature. 1989 Jan 5;337(6202):78–81. doi: 10.1038/337078a0. [DOI] [PubMed] [Google Scholar]
  10. Imaoka T., Lynham J. A., Haslam R. J. Purification and characterization of the 47,000-dalton protein phosphorylated during degranulation of human platelets. J Biol Chem. 1983 Sep 25;258(18):11404–11414. [PubMed] [Google Scholar]
  11. Ingebritsen T. S., Stewart A. A., Cohen P. The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. Eur J Biochem. 1983 May 2;132(2):297–307. doi: 10.1111/j.1432-1033.1983.tb07362.x. [DOI] [PubMed] [Google Scholar]
  12. Karaki H., Mitsui M., Nagase H., Ozaki H., Shibata S., Uemura D. Inhibitory effect of a toxin okadaic acid, isolated from the black sponge on smooth muscle and platelets. Br J Pharmacol. 1989 Oct;98(2):590–596. doi: 10.1111/j.1476-5381.1989.tb12633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kikkawa U., Kishimoto A., Nishizuka Y. The protein kinase C family: heterogeneity and its implications. Annu Rev Biochem. 1989;58:31–44. doi: 10.1146/annurev.bi.58.070189.000335. [DOI] [PubMed] [Google Scholar]
  14. Kim U. H., Kim J. W., Rhee S. G. Phosphorylation of phospholipase C-gamma by cAMP-dependent protein kinase. J Biol Chem. 1989 Dec 5;264(34):20167–20170. [PubMed] [Google Scholar]
  15. Knight D. E., Scrutton M. C. Secretion of 5-hydroxytryptamine from electropermeabilised human platelets. Effects of GTP and cyclic 3',5'-AMP. FEBS Lett. 1987 Oct 19;223(1):47–52. doi: 10.1016/0014-5793(87)80507-0. [DOI] [PubMed] [Google Scholar]
  16. Krishnamurthi S., Wheeler-Jones C. P., Kakkar V. V. Effect of phorbol ester treatment on receptor-mediated versus G-protein-activator-mediated responses in platelets. Evidence for a two-site action of phorbol ester at the level of G-protein function. Biochem J. 1989 Aug 15;262(1):77–81. doi: 10.1042/bj2620077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lerea K. M., Glomset J. A., Krebs E. G. Agents that elevate cAMP levels in platelets decrease thrombin binding. J Biol Chem. 1987 Jan 5;262(1):282–288. [PubMed] [Google Scholar]
  18. Nunn D. L., Watson S. P. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets. Biochem J. 1987 May 1;243(3):809–813. doi: 10.1042/bj2430809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rhee S. G., Suh P. G., Ryu S. H., Lee S. Y. Studies of inositol phospholipid-specific phospholipase C. Science. 1989 May 5;244(4904):546–550. doi: 10.1126/science.2541501. [DOI] [PubMed] [Google Scholar]
  20. Ryu S. H., Kim U. H., Wahl M. I., Brown A. B., Carpenter G., Huang K. P., Rhee S. G. Feedback regulation of phospholipase C-beta by protein kinase C. J Biol Chem. 1990 Oct 15;265(29):17941–17945. [PubMed] [Google Scholar]
  21. Sakon M., Kambayashi J., Kajiwara Y., Uemura Y., Shiba E., Kawasaki T., Mori T. Platelet protein phosphatases and their endogenous substrates. Biochem Int. 1990 Oct;22(1):149–161. [PubMed] [Google Scholar]
  22. Siess W., Lapetina E. G. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C. Biochem J. 1988 Oct 1;255(1):309–318. [PMC free article] [PubMed] [Google Scholar]
  23. Siess W., Lapetina E. G. Prostacyclin inhibits platelet aggregation induced by phorbol ester or Ca2+ ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases. Biochem J. 1989 Feb 15;258(1):57–65. doi: 10.1042/bj2580057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989 Jan;69(1):58–178. doi: 10.1152/physrev.1989.69.1.58. [DOI] [PubMed] [Google Scholar]
  25. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  26. Taylor S. S., Buechler J. A., Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem. 1990;59:971–1005. doi: 10.1146/annurev.bi.59.070190.004543. [DOI] [PubMed] [Google Scholar]
  27. Tyers M., Rachubinski R. A., Stewart M. I., Varrichio A. M., Shorr R. G., Haslam R. J., Harley C. B. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 1988 Jun 2;333(6172):470–473. doi: 10.1038/333470a0. [DOI] [PubMed] [Google Scholar]
  28. Wahl M., Carpenter G. Selective phospholipase C activation. Bioessays. 1991 Mar;13(3):107–113. doi: 10.1002/bies.950130303. [DOI] [PubMed] [Google Scholar]
  29. Watson S. P., Lapetina E. G. 1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis. Proc Natl Acad Sci U S A. 1985 May;82(9):2623–2626. doi: 10.1073/pnas.82.9.2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Watson S. P., McConnell R. T., Lapetina E. G. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem. 1984 Nov 10;259(21):13199–13203. [PubMed] [Google Scholar]
  31. Zieseniss E., Plattner H. Synchronous exocytosis in Paramecium cells involves very rapid (less than or equal to 1 s), reversible dephosphorylation of a 65-kD phosphoprotein in exocytosis-competent strains. J Cell Biol. 1985 Dec;101(6):2028–2035. doi: 10.1083/jcb.101.6.2028. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES